The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of tecotabart vedotin plus toripalimab with or without chemotherapy as first-line treatment for CLDN18.2-positive advanced gastric or gastroesophageal junction adenocarcinoma: Phase II study results.
 
Jin Li
No Relationships to Disclose
 
Haiping Jiang
No Relationships to Disclose
 
Mingzhu Huang
No Relationships to Disclose
 
Lixin Wan
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Yu Zheng
No Relationships to Disclose
 
Aiping Zhou
No Relationships to Disclose
 
Jing Dai
No Relationships to Disclose
 
Jun Zhou
No Relationships to Disclose
 
Rusen Zhao
No Relationships to Disclose
 
Yiping Mou
No Relationships to Disclose
 
Xianglin Yuan
No Relationships to Disclose
 
Ning Wu
No Relationships to Disclose
 
Linbin Dou
Employment - LaNova Medicines
 
Da Fei
Employment - LaNova Medicines
 
Xia Qin
Employment - LaNova Medicines
 
Crystal Qin
Employment - LaNova Medicines